Bioscience News: Breaking Bioscience News, Comments and Articles. - Page: 2

Pressure BioSciences rallies on potential new method for screening GI system using core PCT technology

Pressure BioSciences, (OTCQB: PBIO), a company focused on developing its pressure cycling technology (PCT), says that researchers at Harvard Medical School have published a scientific paper describing a non-invasive method that could potentially scre...

Controversy Lurks As Cloning Technique Yields Embryos With Eye On Stem Cell Therapies

Political and ethical fights over human cloning may follow the latest stem cell therapy advance after scientists created embryos that are genetic copies of living people in an effort to treat diseases such as Alzheimer's. Los Angeles Times: For First Time, Stem Cells Are Produced From Cloning Technique For the first time, scientists have created human embryos that are genetic copies of living peop...

Controversy Lurks As Cloning Technique Yields Embryos For Use In Stem Cell Therapies

Political and ethical fights over human cloning may follow the latest stem cell therapy advance after scientists created embryos that are genetic copies of living people in an effort to treat diseases such as Alzheimer's. Los Angeles Times: For First Time, Stem Cells Are Produced From Cloning Technique For the first time, scientists have created human embryos that are genetic copies of living peop...

Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function Possible

SOUTH EASTON, Mass., May 16, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced the publication in the journal Analytical Chemistry of a study by a team of scientists led by Dr. Bruce Kristal, Associate Professor of Surgery at Harvard Medical School and the Department of Neurosurgery at Brigham and Women's Hospital, entitled: Met...

Source BioScience Interim Management Statement

16th May 2013: Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis services business, today publishes its Interim Management Statement for the year to date. Unless otherwise stated, the financial information referenced below refers to the four months ended 30 April 2013, and the corresponding period last year, this being the latest practicable date to which f...

Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego

SAN DIEGO, May 16, 2013 /PRNewswire/ -- The registration deadline has been extended until May 22 for the Association of Bioscience Financial Officers (ABFO) 2013 National Conference, the premier conference for bioscience financial officers. The conference will be held May 28-31 at the Hilton San Diego Bayfront. "We are putting the finishing touches on this year's conference and want to...

Ambit Biosciences Announces Pricing of Initial Public Offering

SAN DIEGO, May 16, 2013 /PRNewswire/ -- Ambit Biosciences Corporation today announced the pricing of its initial public offering of 8,125,000 shares of its common stock at $8.00 per share.  Ambit has granted the underwriters a 30-day option to purchase up to an additional 1,218,750 shares at the initial public offering price to cover over-allotments, if any.  Ambit's common stock is...

Pacific Biosciences and Sage Science Announce Co-Marketing Partnership

PacBio® RS II With BluePippin™ Size Selection Platform Provides Customers Improved Ability to Sequence Longer DNA Fragments MENLO PARK, Calif. and BEVERLY, Mass., May 16, 2013 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, and Sage Science, a developer of life science products for improving sample preparatio...

Natural 'keystone molecules' punch over their weight in ecosystems

(American Institute of Biological Sciences) Ecosystems are disproportionately influenced by "keystone molecules" that have powerful behavioral effects and contribute to ecosystem structure, according to a general theory described in the June issue of...

Colorado BioScience Association Applauds Signing of The Colorado Advanced Industries Acceleration Act (HB 1001) by Gov. John Hickenlooper

Colorado BioScience Association Applauds Act Designed to Grow Colorado’s High-Tech Sectors The Colorado BioScience Association (CBSA) applauds the signing of The Colorado Advanced Industries Acceleration Act (HB 1001) by Gov. John Hickenlooper today at the University of Northern Colorado in Greeley. The announcement is made by CBSA President & CE...

Ambit bumps shares, lowers price for proposed IPO

Ambit Biosciences Corp. (San Diego, Calif.) amended its IPO and now plans to sell more shares at a lower price. The company plans to sell 8.1 million shares at $8, which would raise $65 million and value the company at $141.7 million. Earlier this mo...

Bayer, QB3 partner on life science startups

The Bayer Healthcare LLC subsidiary of Bayer AG (Xetra:BAYN) partnered with the California Institute for Quantitative Biosciences (QB3) under a three-year deal to evaluate and support life science startups from QB3. The companies said the deal will h...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventrus Biosciences, Inc. - VTUS

NEW YORK, May 15, 2013 /PRNewswire/ --Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Ventrus Biosciences, Inc. ("Ventrus" or the "Company") who ...

PuraMed BioScience®, Inc., Launches Its Business-to-Business Migraine First Aid Kit™ to Promote Workplace Health and Wellness

SCHOFIELD, Wis., May 15, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB: PMBS) announces the launch of its Business-to-Business Migraine First Aid Kit™. The program, which is available to businesses of any size, can help migraine sufferers stay on the job and stay productive by eliminating migraine pain and associated symptoms. "Knowing that migraines are debilit...

Encouraging results with Sangamo's SB-728-T in HIV treatment

USA-based Sangamo BioSciences (Nasdaq: SGMO) has presented new clinical data from its program to develop a ZFP Therapeutic for HIVAIDS. The data, which demonstrate that SB-728-T treatment results in a reduction in the HIV reservoir in HIV-infected su...

Entia hires director of marketing for medical foods and consumer products

SHERWOOD, Ore., May 15, 2013 /PRNewswire/ -- Entia Biosciences, Inc. (OTCQB: ERGO) announced today it has hired Sabrina Jetton to spearhead the Company's product innovation, communications, and branding initiatives as Director of Marketing.  Since joining the team in April, Jetton has been leading the preparations for the upcoming launch of the expanded GROH® hair care and beauty line, w...

Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic, SB-728-T

RICHMOND, Calif., May 15, 2013 /PRNewswire/ --Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of new clinical data from its program to develop a ZFP Therapeutic® for HIV/...

LI-COR Analyzers Monitoring Carbon Dioxide Worldwide as Atmospheric Levels Reach 400 parts per million

On May 13, the National Oceanic and Atmospheric Administration (NOAA) reported a preliminary daily average carbon dioxide (CO2) reading of 400.07 parts per million (ppm) at the Mauna Loa Observatory on the Big Island of Hawaii. On May 9, a reading over 400 ppm was reported at the site for the first time ever. But that reading (400.03 ppm) was later revised...

Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-T

RICHMOND, Calif., May 15, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of new clinical data from its program to develop a ZFP Therapeutic® for HIV/AIDS.  The data, which demonstrate that SB-728-T treatment results in a reduction in the HIV reservoir in HIV-infected subjects, are being presented at the 16th Annual Meeting of the...

CBSA Applauds signing of The Colorado Advanced Industries Acceleration Act

Colorado BioScience Association Applauds signing of The Colorado Advanced Industries Acceleration Act (HB 1001) by Gov. John Hickenlooper Colorado BioScience Association (CBSA) applauds the signing of The Colorado Advanced Industries Acceleration Act...

Harvard Bioscience Announces Retirement of CEO and Appointment of Interim CEO

HOLLISTON, Mass., May 15, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its Board of Directors has appointed David Green, the Company's President and member of the Board since 1996, as interim Chief Executive Officer following...

DARA Reports First Quarter 2013 Financial Results and Operational Highlights

RALEIGH, NC--(Marketwired - May 15, 2013) - DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today its financial results for the first quarter ended March 31, 2013. The Company also summarized the first quarter 2013 operational highlights, its recent developments, and provided a commercial and developmen...

Series A brings in $5.6mm for [Regado Biosciences]

[Duke University] spin-out [Regado Biosciences Inc.] (anti-thrombotics) has raised $5.6mm through its Series A venture round. Aurora Funds participated and was joined by three undisclosed individual investors.

J. Craig Venter Institute's Mobile Genomics Lab Launches First School Visits in San Diego County

LA JOLLA, Calif., May 14, 2013 /PRNewswire-USNewswire/ -- The J. Craig Venter Institute (JCVI) announced today the launch of their mobile genomics laboratory program in the San Diego, California area.  The DiscoverGenomics! Mobile Laboratory is a self-sufficient laboratory on wheels providing middle school students and teachers an opportunity to learn current bioscience concepts and to m...

ChanTest Develops New Cardiotoxicity and Contractility Assay with Human Stem Cell Cardiomyocytes

ChanTest has developed a new assay using ACEA Bioscience’s xCELLigence System, creating several algorithms for twitch detection and kinetic analysis, and has concluded an investigation that suggests twitch impedance is a sensitive tool to assess contraction in a relatively high-throughput assay. Cleveland, OH (PRWEB) May 14, 2013 Cardiovascular (CV) toxicity is a leading contributor to drug wit...